2025-04-14 00:59:53
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
Sunil Healthcare Ltd Q4 FY2022 consolidated profit up at Rs. 4.01 crores
Posted On : 2022-05-06 22:30:11( TIMEZONE : IST )
Sunil Healthcare Ltd has reported Consolidated financial results for the period ended March 31, 2022.
Financial Results (Q4 FY2022) - QoQ Comparison
The company has reported total income of Rs. 32.5325 crores during the period ended March 31, 2022 as compared to Rs. 31.7664 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs. 4.0107 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 2.1618 crores for the period ended December 31, 2021.
The company has reported EPS of Rs. 3.91 for the period ended March 31, 2022 as compared to Rs. 2.11 for the period ended December 31, 2021.
| Financials | Q4 FY2022 | Q3 FY2022 | % Change |
| Total Income | ₹ 32.5325 crs | ₹31.7664 crs |  2.41% |
| Net Profit | ₹4.0107 crs | ₹2.1618 crs | 85.53% |
| EPS | ₹3.91 | ₹2.11 | 85.31% |
Financial Results (Q4 FY2022) - YoY Comparison
The company has reported total income of Rs. 32.5325 crores during the period ended March 31, 2022 as compared to Rs.24.6738 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.4.0107 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.-0.5976 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.3.91 for the period ended March 31, 2022 as compared to Rs.-0.58 for the period ended March 31, 2021.
| Financials | Q4 FY2022 | Q4 FY2021 | % Change |
| Total Income | ₹ 32.5325 crs | ₹24.6738 crs | 31.85% |
| Net Profit | ₹4.0107 crs | ₹-0.5976 crs | 771.13% |
| EPS | ₹3.91 | ₹-0.58 | 774.14% |
Financial Results (Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.120.8396 crores during the Financial Year ended March 31, 2022 as compared to Rs.96.1989 crores during the Financial Year ended March 31, 2021.
The company has posted net profit / (loss) of Rs.6.4206 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.-0.6379 crores for the Financial Year ended March 31, 2021.
The company has reported EPS of Rs.6.26 for the Financial Year ended March 31, 2022 as compared to Rs.-0.62 for the Financial Year ended March 31, 2021.
| Financials | Year Ended FY2022 | Year Ended FY2021 | % Change |
| Total Income | ₹120.8396 crs | ₹96.1989 crs | 25.61% |
| Net Profit | ₹6.4206 crs | ₹-0.6379 crs | 1,106.52% |
| EPS | ₹6.26 | ₹-0.62 | 1,109.68% |
Shares of Sunil Healthcare Ltd was last trading in BSE at Rs. 67.70 as compared to the previous close of Rs. 68.75. The total number of shares traded during the day was 884 in over 21 trades.
The stock hit an intraday high of Rs. 68.35 and intraday low of 65.35. The net turnover during the day was Rs. 59008.00.
